News
James C. Smith elected to Pfizer’s Board of Directors
Pfizer Inc. has announced the election of James C. Smith to its Board of Directors, effective immediately. Mr. Smith also was appointed to the...
Techno Trends
Insourcing IV Sterile Compounding
Determined to cement access to reliable and safe sources for crucial IV drug admixtures, a growing number of hospitals are bringing production of compounded...
Press Releases
Cancer research departments need to think beyond checkpoint inhibitors
Cancer immunotherapy research departments need to break their obsession with the latest flavour of the month - checkpoint inhibitors - and concentrate more on...
News
US nets biggest penalties for fraud from pharma
The US crackdown on healthcare fraud is paying huge dividends to the exchequer, accounting for three quarters of the money recovered as penalties in...
Press Releases
Provepharm and Dr Franz Kohler Chemie partner to provide Methylthioninium chloride Proveblue solution for injection to Germany
Proveblue(R) is the methylthioninium chloride or Methylene Blue active substance patented by Provepharm, compliant with current European Pharmacopeia standards Provepharm, a...
Press Releases
Ferrer initiates second phase III clinical study for Ozenoxacin in adult and paediatric patients with impetigo
Ozenoxacin, a novel bactericidal non-fluorinated quinolone that successfully completed a first phase III clinical trial in adult and paediatric patients with impetigo, is available...
News
Gene Expression Profiling Drives Personalized Medicine Worldwide, Finds Frost & Sullivan
Large amounts of information generated by gene expression profiling will increase implementation of data management tools Gene expression profiling...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read